研究実績  |  RESULTS ACHIEVEMENT

英文論文

    2021
  • Horii T*, Oikawa Y*, Atsuda K, Shimada A. On-label use of sodium-glucose cotransporter 2 inhibitors may increase the risk of diabetic ketoacidosis in patients with type 1 diabetes. J Diabetes Investig. 2021 Sep;12(9):1586-1593. (*: These authors contributed equally to this work.)

  • 2021
  • Nakano T, Aochi H, Masataka H, Takenaka Y, Fujita K, Tamura M, Soma H, Kamezawa H, Koizumi T, Shibuya H, Inomata R, Okuda A, Murakoshi T, Shimada A, Inoue I. Effects of Pparγ1 deletion on late-stage murine embryogenesis and cells that undergo endocycle. Dev Biol. 2021 Oct;478:222-235.

  • 2021
  • Yasuda S, Inoue I, Shimada A. Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly. Intern Med. 2021;60(15):2451-2459. 

  • 2021
  • Kurokawa Y, Oikawa Y, Shimada A, Yajima K. Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report. Diabetol Int. 2021 (In press). 

  • 2021
  • Sugawa SW, Yoshida Y, Hikima Y, Sato H, Shimada A, Noda M, Kushiyama A. Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study. J Diabetes Res. 2021 Jul 17;2021:7572326.

  • 2021
  • Horii T, Oikawa Y, Kunisada N, Shimada A, Atsuda K. Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose co-transporter 2 inhibitors: A nationwide cohort study. J Diabetes Investig. 2021 (In press)

  • 2021
  • Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S. Comparison of the Japan Society of Clinical Chemistry reference method and CDC methodfor HDL and LDL cholesterol measurements using fresh sera. Pract Lab Med. 2021 May;25:e00228. 

  • 2021
  • Yamada Y, Sugi K, Gatate Y, Senbonmatsu T, Inoue I, Fukushima K, Iguchi A, Nakajima H, Muramatsu T, Nakano S, Tada H. Premature acute myocardial infarction in a young patient with sitosterolemia. CJC Open. 2021 May 4;3(8):1085-1088.

  • 2021
  • Yasuda S, Inoue K, Iida S, Oikawa Y, Namba A, Isshiki M, Inoue I, Kamei Y, Shimada A, Noda M. Differences in the birthweight of infants born to patients with early- or mid-to-late-detected gestational diabetes mellitus who underwent guideline-based glycemic control. J Diabetes Complications. 2021 Apr;35(4):107850.

  • 2021
  • Sasako T, Ueki K, Miyake K, Okazaki Y, Takeuchi Y, Ohashi Y, Noda M, Kadowaki T. Effect of a multifactorial intervention on fracture in patients with type 2 diabetes: sub-analysis of the J-DOIT3 study.  J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2116-e2128. 

  • 2021
  • Kawasaki E, Oikawa Y, Okada A, Kanatsuna N, Kawamura T, Kikuchi T, Terasaki J, Miura J, Ito Y, Hanafusa T. Different Interaction of Onset Age and Duration of Type 1 Diabetes on the Dynamics of Autoantibodies to IA-2 and ZnT8. J Diabetes Investig. 2021 Apr;12(4):510-515.

  • 2021
  • Koizumi T, Kaneda H, Komiyama N, Inoue I, Muramatsu T, Nakajima K. Lipoprotein Profiles before Heparin Administration in Patients with or without Coronary Thrombosis Following Atherosclerosis. Ann Vasc Dis. 2021 Mar 25;14(1):31-38.

  • 2021
  • Satomura A*, Oikawa Y*, Nakanishi S, Takagi S, Mizutani G, Iida S, Nakayama H, Haga Y, Nagata M, Maesaki S, Mimura T, Shimada A. Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report. Diabetol Int. 2021 Mar 1:1-6. (*: These authors contributed equally to this work.)

  • 2021
  • Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes.  Kidney Int. 2021 Jan;99(1):256-266. 

  • 2021
  • Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787.

  • 2020
  • Horii T, Oikawa Y, Kunisada N, Shimada A, Atsuda K. Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study. BMJ Open Diabetes Res Care. 2020 Nov;8(2):e001856.

  • 2020
  • Ikegami H, Imagawa A, Shimada A. Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000. Diabetol Int. 2020 Oct;11(4):342-343.

  • 2020
  • Shimada A, Ikegami H. Twenty years since the discovery of fulminant type 1 diabetes. Diabetol Int. 2020 Oct;11(4):309.

  • 2020
  • Oikawa Y, Shimada A. Possible involvement of autoimmunity in fulminant type 1 diabetes. Diabetol Int. 2020 Oct;11(4):329–335. 

  • 2020
  • Teratani T, Toma-Fukai S, Nakamura Y, Itoh T, Shimizu H, Shiraishi Y, Sugihara N, Higashiyama M, Shimizu T, Inoue I, Takenaka Y, Hokari R, Adachi T, Shimizu T, Miura S, Kanai T. Redox-dependent PPARγ/Tnpo1 complex formation enhances PPARγ nuclear. Free Radic Biol Med. 2020 Aug 20;156:45-56.

  • 2020
  • Nakano T, Inoue I, Takenaka Y, Ito R, Kotani N, Sato S, Nakano Y, Hirasaki M, Shimada A, Murakoshi T. Ezetimibe impairs transcellular lipid trafficking and induces large lipid droplet formation in intestinal absorptive epithelial cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158808.

  • 2020
  • Wilunda C, Sawada N, Goto A, Yamaji T, Iwasaki M, Tsugane S, Noda M. Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study. Eur J Nutr. 2020 Aug;59(5):2075-2087.

  • 2020
  • Kikuchi H, Inoue S, Odagiri Y, Ihira H, Inoue M, Sawada N, Noda M, Tsugane S. Intensity-specific validity and reliability of the Japan Public Health Center-based prospective study-physical activity questionnaire.  Prev Med Rep. 2020 Aug 6;20:101169. 

  • 2020
  • Saito D, Nakajima R, Yasuda S. Examination of Malignant Findings of Thyroid Nodules Using Thyroid Ultrasonography. J Clin Med Res. 2020;12(8):499-507.

  • 2020
  • Isshiki M, Sakuma I, Hayashino Y, Sumita T, Hara K, Takahashi K, Shiojima I, Satoh-Asahara N, Kitazato H, Ito D, Saito D, Hatano M, Ikegami Y, Iida S, Shimada A, Noda M. Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration. Endocr J. 2020 Nov 28;67(11):1127-1138.

  • 2020
  • Yamazaki C, Goto A, Iwasaki M, Sawada N, Oba S, Noda M, Iso H, Koyama H, Tsugane S. Body mass index and mortality among middle-aged Japanese individuals with diagnosed diabetes: The Japan Public Health Center-based prospective study (JPHC study).  Diabetes Res Clin Pract. 2020 Jun;164:108198.

  • 2020
  • Koba S, Inoue I, Cyrille M, Lu C, Inomata H, Shimauchi J, Kajinami K. Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial. J Atheroscler Thromb. 2020 May 1;27(5):471-484.

  • 2020
  • Yamamoto J, Ishihara J, Kotemori A, Yoshizaki T, Goto A, Mizoue T, Noda M, Sawada N, Tsugane S. Association between Okinawan vegetables consumption and risk of type 2 diabetes in Japanese communities: The JPHC Study. J Epidemiol. 2020 May 5;30(5):227-235.

  • 2020
  • Akter S, Kuwahara K, Matsushita Y, Nakagawa T, Konishi M, Honda T, Yamamoto S, Hayashi T, Noda M, Mizoue T; Japan Public Health Center-based Prospective Study Group. Serum 25-hydroxyvitamin D3 and risk of type 2 diabetes among Japanese adults: the Hitachi Health Study. Clin Nutr. 2020 Apr;39(4):1218-1224.

  • 2020
  • Kawasaki E, Oikawa Y, Okada A, Kanatsuna N, Kawamura T, Kikuchi T, Terasaki J, Miura J, Ito Y, Hanafusa T. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes. J Diabetes Investig. 2020 Sep;11(5):1181-1187.

  • 2020
  • Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A; Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics. Statin Intolerance Clinical Guide 2018. J Atheroscler Thromb. 2020 Apr 1;27(4):375-396.

ACCESSご案内

埼玉医科大学

埼玉医科大学病院

〒350-0495 埼玉県入間郡毛呂山町毛呂本郷38
TEL: 049-276-1204
FAX: 049-294-9752

お車をご利用される方
鶴ヶ島インターから約10km(約20~30分)
詳しくはこちら

電車・バスをご利用される方
池袋駅より東毛呂駅まで約1時間
東毛呂駅からバス(約5分)もしくは徒歩(約20分)
詳しくはこちら

本フォームは医療従事者専用となっております。ご病状やお薬、検査、予約など診療に関する患者さんからのご相談は、法律上、一切お受けすることができません。ご理解のほどよろしくお願いいたします。